These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16925158)

  • 21. Who should receive a statin these days? Lessons from recent clinical trials.
    Shepherd J
    J Intern Med; 2006 Oct; 260(4):305-19. PubMed ID: 16961668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erectile dysfunction: physical exercise, losing weight, stop smoking, reducing alcohol, relaxing, it could also work!].
    Wisard M
    Rev Med Suisse; 2007 Dec; 3(136):2773-4, 2776, 2778. PubMed ID: 18183811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T
    Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin for prevention of myocardial infarction and stroke: is the right dose 81 or 160 mg/day?
    Dalen JE
    J Am Coll Cardiol; 2009 May; 53(21):2010; author reply 2010. PubMed ID: 19460618
    [No Abstract]   [Full Text] [Related]  

  • 26. New WHO pocket-charts will save lives by predicting heart attack and stroke.
    Cent Eur J Public Health; 2007 Dec; 15(4):146. PubMed ID: 18318046
    [No Abstract]   [Full Text] [Related]  

  • 27. [For prevention of cardiovascular diseases: statins in old age?].
    MMW Fortschr Med; 2006 Sep; 148(38):16. PubMed ID: 17036955
    [No Abstract]   [Full Text] [Related]  

  • 28. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational research: is there a future?
    Verrier ED
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1409-11. PubMed ID: 17532929
    [No Abstract]   [Full Text] [Related]  

  • 30. Chromium: the forgotten mineral.
    Harv Mens Health Watch; 2007 Jan; 11(6):6-7. PubMed ID: 17323489
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of educational programs in prophylaxis of chronic diseases].
    Baksheev VI; Kolomoets NM
    Voen Med Zh; 2006 Mar; 327(3):34-8. PubMed ID: 16737073
    [No Abstract]   [Full Text] [Related]  

  • 32. The challenge of stopping the knocking down of metabolic dominos upstream.
    Katsuya T; Morishita R
    Hypertens Res; 2010 Jun; 33(6):529-30. PubMed ID: 20463682
    [No Abstract]   [Full Text] [Related]  

  • 33. 'Million Hearts' targets cardiovascular disease, stroke.
    Murtha M
    J Ark Med Soc; 2012 Dec; 109(7):132-3. PubMed ID: 23304846
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case against low-volume percutaneous coronary intervention centers.
    O'Neill WW
    Circulation; 2009 Aug; 120(7):546-8. PubMed ID: 19652088
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychosocial and behavioral aspects of cardiovascular disease prevention in men and women.
    Orth-Gomér K
    Curr Opin Psychiatry; 2007 Mar; 20(2):147-51. PubMed ID: 17278913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study.
    Heidemann C; Hoffmann K; Klipstein-Grobusch K; Weikert C; Pischon T; Hense HW; Boeing H
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):65-71. PubMed ID: 17301629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
    Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
    Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Implications of the REACH registry for neurologists].
    Roquer J
    Med Clin (Barc); 2009 Sep; 132 Suppl 2():30-3. PubMed ID: 19631836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacoeconomic analysis: results of the REACH registry].
    Suárez C; Abadía C; Echevarria A
    Med Clin (Barc); 2009 Sep; 132 Suppl 2():41-3. PubMed ID: 19631839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.